HIFU evaluated as second-line treatment for prostate Cancer

March 1, 2002

Bangkok, Thailand - High-intensity focused ultrasound (HIFU) may serve as an alternative, second-line treatment for prostate cancer patients who are poor candidates for more common primary treatment modalities